Valuation: PLC Systems Inc.

Market Cap 4.56M 3.97M 3.75M 3.41M 6.38M 437M 6.41M 44.95M 17.35M 222M 17.12M 16.74M 715M P/E 2020
-0.28x
P/E 2021 -0.43x
Enterprise Value -8.93M -7.79M -7.35M -6.68M -12.51M -857M -12.56M -88.06M -33.98M -436M -33.54M -32.79M -1.4B EV / Sales 2020
1.77x
EV / Sales 2021 -0.22x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
Manager TitleAgeSince
Director of Finance/CFO 62 01/07/2014
Change 5-day change 1-year change 3-year change Capi.($)
-1.04%+6.83%+35.84%+29.03% 241B
-0.32%+5.83%+9.58%-16.76% 149B
+2.55%+6.55%-10.35%+34.72% 139B
-0.48%+0.84%-55.70%-19.89% 62.81B
+0.01%+4.61%+18.61%+22.67% 50.87B
-0.01%-3.13%-19.48%-17.42% 48.21B
+0.08%+6.49%+23.87%+39.12% 44.11B
-1.88%+3.25%+40.14%+53.82% 41.42B
-2.27%+16.07%+133.21%+73.20% 36.18B
Average -0.49%+5.47%+19.52%+22.05% 90.26B
Weighted average by Cap. -0.38%+5.73%+15.59%+18.45%

Financials

2020 2021
Net sales 5.48M 4.78M 4.51M 4.1M 7.68M 526M 7.71M 54.04M 20.85M 267M 20.58M 20.12M 860M 6.43M 5.6M 5.29M 4.8M 9M 617M 9.04M 63.38M 24.46M 313M 24.14M 23.6M 1.01B
Net income -21.92M -19.11M -18.04M -16.39M -30.7M -2.1B -30.83M -216M -83.41M -1.07B -82.32M -80.5M -3.44B -22.03M -19.21M -18.14M -16.47M -30.86M -2.11B -30.99M -217M -83.83M -1.07B -82.74M -80.91M -3.46B
Net Debt -530K -462K -436K -396K -742K -50.86M -746K -5.23M -2.02M -25.86M -1.99M -1.95M -83.19M -13.49M -11.76M -11.1M -10.08M -18.89M -1.29B -18.97M -133M -51.33M -658M -50.66M -49.54M -2.12B
Logo PLC Systems Inc.
Viveve Medical, Inc. designs, develops, manufactures and markets a platform medical technology, Cryogen-cooled Monopolar RadioFrequency (CMRF). The Company’s CMRF technology is delivered through a radiofrequency generator, handpiece and treatment tip, which collectively, is referred to as the Viveve System. The Viveve System is marketed for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence (SUI). In the United States, the Viveve System is indicated for use in general surgical procedures for electrocoagulation and hemostasis. The Viveve System is cleared for marketing in approximately 48 countries throughout the world, including North America, Asia Pacific, Europe, the Middle East and Latin America countries. The Company’s wholly owned subsidiaries include Viveve, Inc. and Viveve BV.
Employees
-
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!